Wall Street Zen Upgrades Revvity (NYSE:RVTY) to “Buy”

Revvity (NYSE:RVTY) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other equities research analysts have also commented on RVTY. JPMorgan Chase & Co. raised their price objective on shares of Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 target price on Revvity in a report on Tuesday, February 3rd. The Goldman Sachs Group started coverage on Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price target on the stock. TD Cowen reiterated a “hold” rating on shares of Revvity in a report on Tuesday, February 3rd. Finally, Wells Fargo & Company lifted their target price on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Five analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $113.67.

Revvity Price Performance

Shares of RVTY opened at $98.23 on Friday. The stock has a 50 day simple moving average of $103.31 and a 200 day simple moving average of $96.51. Revvity has a 52-week low of $81.36 and a 52-week high of $120.39. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. The firm has a market capitalization of $10.98 billion, a PE ratio of 47.23, a P/E/G ratio of 2.09 and a beta of 1.10.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The firm had revenue of $772.06 million for the quarter, compared to the consensus estimate of $759.81 million. During the same period last year, the company posted $1.42 EPS. The business’s quarterly revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Sell-side analysts predict that Revvity will post 4.94 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the 2nd quarter valued at about $32,000. Cromwell Holdings LLC increased its position in Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after buying an additional 198 shares during the last quarter. MUFG Securities EMEA plc acquired a new position in Revvity during the second quarter worth approximately $34,000. Headlands Technologies LLC bought a new stake in Revvity in the second quarter valued at approximately $49,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $51,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.